|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 20739585.6 (espacenet) (Federated) (European Patent Register), 20200703 | | Patent/reg. no. and date | DK/EP 3993796, 20240221 | | Publication date | 20220511 | | Priority no. and date | US 201962870990 P, 20190705, US 202062985465 P, 20200305 | | EP pub. no. and date |
EP 3993796 20220511 | | Effective date | | | Applicant/owner | GlaxoSmithKline Intellectual Property Development
Limited, GSK Medicines Research Centre
Gunnels Wood Road
Stevenage SG1 2NY, GB | | Applicant ref. no. | | | Inventor | SCANGARELLA-OMAN, Nicole, GlaxoSmithKline 1250 South Collegeville Road
Collegeville, Pennsylvania 19426, US | | Representative | | | Opponent | | | IPC Class | A61K 31/4985 (2006.01) , A61K 31/65 (2006.01) , A61P 13/00 (2006.01) , A61P 15/00 (2006.01) , A61P 31/04 (2006.01) | | Title | COMBINATION FOR THE TREATMENT OF INFECTIONS CAUSED BY MYCOPLASMA GENITALIUM | | Int. application no. | EP2020068754 | | Int. publication no. | WO2021004910 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
